Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factors.

Clinical and translational radiation oncology·2024
Same author

Improved nationwide survival of sarcoma patients with a network of reference centers.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

A Prospective Study of Arterial Spin Labelling in Paediatric Posterior Fossa Tumour Survivors: A Correlation with Neurocognitive Impairment.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Place of radiotherapy for treatment of metastatic cervical, vaginal and endometrial uterine cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same journal

Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.8K

[Brachytherapy for sarcomas].

A Ducassou1, C Haie-Méder2, M Delannes1

  • 1Département de radiothérapie et de curiethérapie, institut Claudius-Regaud, IUCT-Oncopôle, 1, avenue Joliot-Curie, 31059 Toulouse cedex, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|September 12, 2016
PubMed
Summary
This summary is machine-generated.

Conservative surgery plus radiotherapy is standard for soft tissue sarcomas. Brachytherapy offers an alternative or boost, requiring close surgeon-radiologist collaboration for optimal outcomes in extremities sarcomas.

Keywords:
BrachytherapyCuriethérapieIntersitialInterstitielleIntraoperativeIntraopératoireLimbMembresPaediatricsPédiatrieSarcomaSarcomes

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K

Related Experiment Videos

Last Updated: Mar 15, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.8K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Extremities soft tissue sarcomas standard treatment involves conservative surgery and external beam radiotherapy.
  • Brachytherapy is an alternative or boost radiation technique for specific cases, particularly when microscopic positive resection is anticipated.

Purpose of the Study:

  • To review the role and application of brachytherapy in the local treatment of soft tissue sarcomas of the extremities.
  • To highlight the importance of multidisciplinary collaboration in brachytherapy procedures.

Main Methods:

  • Discussion of brachytherapy techniques including low-dose rate (LDR), pulsed-dose rate (PDR), and high-dose rate (HDR).
  • Emphasis on the necessity of close interaction between radiation oncologists and surgeons during brachytherapy implantation.
  • Review of available long-term data for LDR brachytherapy and current trends towards PDR and HDR.

Main Results:

  • Brachytherapy can be used as a primary treatment or boost, especially for high-risk areas after resection.
  • Effective use requires precise surgical and radiological planning to minimize side effects.
  • Long-term data supports LDR brachytherapy, while PDR and HDR are increasingly utilized.

Conclusions:

  • Brachytherapy is a valuable component in the multidisciplinary management of soft tissue sarcomas, particularly in the extremities.
  • Careful planning and collaboration are crucial for successful brachytherapy outcomes.
  • Paediatric sarcomas treated with brachytherapy require specialized management in reference centers.